Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Director/PDMR Shareholding

23 May 2025 16:00

RNS Number : 0444K
Experian plc
23 May 2025
Β 

Experian plc

Β 

Β 

Director/PDMR Shareholding

Β 

Β 

23 May 2025 - Experian plc, the global data and technology company, (the "Company"), hereby notifies the market that it has received the following individual notification relating to a purchase of shares by Eduardo Vassimon, a non-executive director of the Company.

Β 

The notification was made under article 19.1 of the UK Market Abuse Regulation ('MAR'). This announcement is made in accordance with Article 19.3 of MAR.

Β 

Β 

1 - Details of the person discharging managerial responsibilities / person closely associated

Β 

Β 

Β 

Natural Person

Eduardo Vassimon

Β 

Β 

2 - Reason for the notification

Β 

Β 

Β 

Position/status

Non-executive director

Β 

Β 

Initial notification / Amendment

Initial Notification

Β 

Β 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

Β 

Β 

Β 

Full name of the entity

Experian plc

Legal Entity Identifier code

6354,350RXXHHYT1JTSZ26

Β 

Β 

Β 

4 - Details of the transaction(s)

Β 

Β 

Β 

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary shares of US 10 cents each in Experian plc

Β 

Identification Code

GB00B19NLV48

Β 

Β 

Nature of transaction

Purchase of Ordinary Shares (EXPN)

Β 

Β 

Currency

GBP

Β 

Β 

Prices(s) and volumes(s)

Price

Volume

Β£38.7508

4,350

Β 

Β 

Aggregated Information

Price

Volume

Β£38.7508

4,350

Β 

Β 

Date of Transaction

Β 

2025-05-21

Β 

Β 

Place of transaction

XLON

Β 

Β Β 

Contact:

Β 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

Β 

Β 

About Experian

Β 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHPPUPCAUPAGCW
Date   Source Headline
3rd Sep 202510:04 amRNSAdditional Listing
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20251:38 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20254:30 pmRNSDirector/PDMR Shareholding
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 202512:50 pmRNSTotal Voting Rights
16th Jul 20251:58 pmRNSAppointment of Chair of the Remuneration Committee
16th Jul 20251:00 pmRNSResult of AGM
15th Jul 20257:00 amRNSTrading update, first quarter
30th Jun 20254:57 pmRNSTotal Voting Rights
30th Jun 20252:30 pmRNSShare repurchase programme
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20255:57 pmRNSSecond interim dividend
27th Jun 20257:00 amRNSTransaction in Own Shares
26th Jun 20257:00 amRNSTransaction in Own Shares
25th Jun 202511:00 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSTransaction in Own Shares
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 20257:00 amRNSTransaction in Own Shares
20th Jun 20257:00 amRNSTransaction in Own Shares
19th Jun 20257:00 amRNSTransaction in Own Shares
18th Jun 20257:00 amRNSTransaction in Own Shares
17th Jun 20252:00 pmRNSDirector/PDMR Shareholding
16th Jun 20253:30 pmRNSShare repurchase programme
11th Jun 20254:00 pmRNSDirector/PDMR Shareholding
11th Jun 20259:37 amRNSBond Issue
6th Jun 202511:30 amRNSAnnual Financial Report
30th May 20253:00 pmRNSTotal Voting Rights
30th May 20259:30 amRNSElections for Second Interim Dividend
28th May 20259:09 amRNSAdditional Listing
23rd May 20254:00 pmRNSDirector/PDMR Shareholding
21st May 20259:36 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.